首页> 外文期刊>The lancet oncology >Anti-angiogenic therapies in metastatic breast cancer-an unfulfilled dream.
【24h】

Anti-angiogenic therapies in metastatic breast cancer-an unfulfilled dream.

机译:转移性乳腺癌的抗血管生成治疗是一个未实现的梦想。

获取原文
获取原文并翻译 | 示例
           

摘要

Vascular endothelial growth factor A (VEGFA) belongs to a family of glycoproteins that include VEGFB, VEGFC, VEGFD, VEGFE, and placental growth factor. VEGF has been recognised as the most important stimulus for angiogenesis. Angiogenesis is an important step for the growth and progression of cancers. In adulthood, angiogenesis is seen during menstrual cycles in the endometrial tissue and ovaries, and during the wound-healing process.
机译:血管内皮生长因子A(VEGFA)属于糖蛋白家族,包括VEGFB,VEGFC,VEGFD,VEGFE和胎盘生长因子。 VEGF已经被认为是血管生成的最重要刺激。血管生成是癌症生长和进展的重要步骤。在成年期,在子宫内膜组织和卵巢的月经周期以及伤口愈合过程中可见血管生成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号